16:35 , Jan 12, 2018 |  BC Week In Review  |  Financial News

Braeburn raises $110M mezzanine round

Braeburn Pharmaceuticals Inc. (Princeton, N.J.) closed on Jan. 10 a $110 million mezzanine financing led by new investor Wellington Capital Management. New investors Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management...
22:50 , Jan 10, 2018 |  BC Extra  |  Financial News

Braeburn raises $110M in mezzanine round

Braeburn Pharmaceuticals Inc. (Princeton, N.J.) said it closed a $110 million mezzanine financing led by new investor Wellington Capital Management. New investors Avista Capital Partners, RA Capital Management, New Leaf Venture Partners, Deerfield Management and...
03:57 , May 12, 2017 |  BC Week In Review  |  Financial News

OptiNose raises $37M in series D

OptiNose Inc. (Yardley, Pa.) raised $37 million in a series D round led by Fidelity Management & Research Company on May 9. Avista Capital Partners , Entrepreneurs Fund and existing investors also participated. OptiNose's lead...
20:16 , May 9, 2017 |  BC Extra  |  Financial News

OptiNose raises $37M in series D round

OptiNose Inc. (Yardley, Pa.) raised $37 million in a series D round led by Fidelity Management & Research Company. Avista Capital Partners , Entrepreneurs Fund and existing investors also participated. OptiNose's lead candidate OPN-375 is...
07:00 , Oct 12, 2015 |  BC Week In Review  |  Financial News

OptiNose completes venture financing

OptiNose Inc. , Yardley, Pa.   Business: Drug delivery   Date completed: 2015-10-06   Type: Venture financing   Raised: Not disclosed   Investors: Avista Capital Partners ; WFD Ventures LLC; Entrepreneurs Fund   Note: OptiNose...
07:00 , Mar 31, 2014 |  BC Week In Review  |  Company News

Upsher-Smith, Vertical Pharmaceuticals deal

Vertical acquired Upsher-Smith's rights to Divigel estradiol gel, probiotic supplement Provella and prenatal vitamin Nexa Plus. The companies did not disclose financial terms. Divigel, a 0.1% estradiol gel, is approved in the U.S. to treat...
08:00 , Jan 13, 2014 |  BioCentury  |  Finance

Analyst tracks

Analyst tracks George Zavoico joined H.C. Wainwright & Co. LLC as a managing director and senior biotechnology analyst. Zavoico was a managing director and life sciences research analyst at MLV & Co. Banker tracks Baird...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Company News

Trigen Laboratories, Vertical Pharmaceuticals Inc., Avista Capital Partners deal

On Dec. 16, 2013, private equity firm Avista acquired an undisclosed controlling equity interest in Vertical/Trigen Holdings, which owns Vertical and Trigen. Avista said both entities will continue to market their existing product lines. Vertical...
08:00 , Nov 25, 2013 |  BioCentury  |  Finance

Private equity tracks

Private equity tracks Newton Aguiar, a partner at Avista Capital Partners , will depart at year end to pursue undisclosed opportunities in the European private equity healthcare sector. Venture tracks Michael Gilman joined Atlas Venture...
07:00 , Sep 17, 2012 |  BioCentury  |  Finance

Banker tracks

Banker tracks Jeffrey Wasserstein joined Greenhill & Co. as managing director focused on the pharmaceutical sector. He was SVP of business development and strategy at Fougera Pharmaceuticals Inc., which was acquired in July by the...